S&P Futures
4,564.25 +5.00 (+0.11%) Dow Futures
35,596.00 +108.00 (+0.30%) Nasdaq Futures
16,055.75 +32.00 (+0.20%) Russell 2000 Futures
1,807.20 +1.40 (+0.08%) Crude Oil
78.04 +0.18 (+0.23%) Gold
2,062.60 -4.50 (-0.22%)
iRobot Corporation (IRBT)
After hours:
Chart Events
Performance Outlook
| Previous Close | 35.48 |
| Open | 35.31 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 1100 |
| Day's Range | 34.71 - 36.94 |
| 52 Week Range | 28.23 - 53.25 |
| Volume | |
| Avg. Volume | 541,022 |
| Market Cap | 1.01B |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -11.81 |
| Earnings Date | Feb 12, 2024 - Feb 16, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.47 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for IRBT
Related Research
- iRobot CorporationIRBT: Lowering target price to $31.00IROBOT CORP has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.RatingFair ValueEconomic Moat8 days agoArgus Research
ReutersEU Commission lawyers initially opposed warning Amazon on iRobot deal - sources
European Commission lawyers initially opposed sending a warning to Amazon over its $1.4 billion acquisition of robot vacuum maker iRobot, three people with direct knowledge of the matter said on Wednesday. The Commission's legal service did not think a statement of objections regarding the deal was warranted, in contrast with antitrust officials handling the case, the people said. Without such a charge sheet, the deal would have been cleared unconditionally.
Barrons.comThese Stocks Moved the Most Today: Micron, Boeing, Acelyrin, PDD, ChargePoint, Affirm, and More
Micron falls after the chip maker boosts fiscal first-quarter earnings guidance but forecasts higher operating expenses. Boeing stock rises after being upgraded.
Barrons.comThe Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
